Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatocyte replacement refers to therapeutic strategies aimed at substituting diseased or dysfunctional liver cells (hepatocytes) with functional hepatocytes, typically by transplantation. This approach partially restores hepatic metabolic, synthetic, and detoxification capacity in patients with inherited metabolic liver diseases, acute liver failure, or select conditions where full organ transplantation is undesirable or infeasible. Unlike liver transplantation, hepatocyte transplantation is less invasive, may be repeated, and does not require removal of the native organ, but its clinical efficacy is often limited by immune rejection, poor cell engraftment, and limited cell supply.
Functional replacement of diseased/dysfunctional hepatocytes with healthy ones; Restoration/compensation of lost metabolic and synthetic functions of the liver
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatocyte replacement (null).